Chronic lymphocytic leukaemia+1
Not yet recruitingStudy of Ibrutinib Plus Ritonavir in Adults with Chronic Lymphocytic Leukemia, Lymphoplasmacytic Lymphoma, and Mantle Cell Lymphoma
Study of Ibrutinib Plus Ritonavir in Adults with Chronic Lymphocytic Leukemia, Lymphoplasmacytic Lymphoma, and Mantle Cell Lymphoma
- Disease:Chronic lymphocytic leukaemiaMantle cell lymphoma
- Substances:IbrutinibRitonavir
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ibrutinib
- Sponsor:Haemato Oncology Foundation For Adults Netherlands
